1Jones P S, Savory R R, Barratt P, et a1. Chromosomal localization, imducibility, tissue-specific expression and strain differences in three murine peroxisome-proliferator-activated- receptor genes. Eur J Biochem.,1995,233:219~226
2Skogsberg J, Kannisto K, Roshani L, et al. Characterization of the human peroxisome proliferator activated receptor delta gene and its expression. Int J Mol Med.,2000,6:73~81
3Moras D, Gronemeyer H. The nuclear receptor ligand-binding domain: structure and function Curr Opin Cell Biol,1998,10:384~391
4Dreyer C, Keller H, Mahfoudi A, et al. Positive regulation of theperoxisomal b-oxydation pathway by fatty acids through activation of peroxisomepro liferator-activated receptors (PPAR). Biol Cell,1993,77:67~76
5Braissant O, Wahli W. Differential expression of peroxisome proliferator-activated receptor-α, -β and -γ during rat embryonic development.Endocrinology,1998,139:2748~2754
6Komar C M, Braissant O, Wahli W, et al. Expression and localization of PPARs in the rat ovary during follicular development and the periovulatory period. Endocrinology,2001,142:4831~4838
7Auboeuf D, Rieusset J, Fajas L, et al. Tissue distribution and quantification of the expression of mRNAs of peroxisomeproliferator-activated receptors and liver X receptor-cc in humans: no alteration in adipose tissue of obese and NIDDM patients. Diabetes,1997,48:1319~1327
8Barak Y, Liao D, He W et al. Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectalcancer. Proc Natl Acad Sci USA, 2002,99:303~308
9Cross 1C, Werb Z, Fisher S J. Implantation and the placenta: key pieces of the development puzzle. Science. 1994,266:1508~1518
10 Barak Y, Nelson M C, Ong E S, et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell,1999,(4):585~595
11 Lim H, Ma L, Ma WG, et al. Hoxa-10 regulates uterine stromal cell responsiveness to progesterone during implantation and decidualization in the mouse. Mol pnrlnrrinnl,1999,(l1):1005~1017
12 Tamai Y, Ishikawa T, Bosl M R, et al. Cytokeratins 8 and 19 in the mouse placental development. J Cell Biol.,2000,151:563~572
13 Peters J M, Lee S S, Li W, et al. Gonzalez FJ.Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta). Mol Cell Biol.,2000,20:5119~5128
14 Saluja 1, Granneman JG, Skoff RP. PPAR delta agonists stimulate oligodendrocyte differentiation in tissue culture.Glia.,2001,33:191~204
15Matsuura H, Adachi H, Smart RC, et al. Correlation between expression of peroxisome proliferator-activated receptor beta and squamous differentiation in epidermal and tracheobronchial epithelial cells. Mol Cell Endocrinol.,1999,147:85~92
16Shu H, Wong B, Zhou G, et al. Activation of PPARa or y reduces secretion of matrix metal loproteinase 9 but not interleukin 8 from human monocytic THP-1 cells. Biochem Biophys Res Commun.,2000,267:345~349
17 Komar C M, Thomas E, Curry Jr. Localization and Expression of Messenger RNAs for the Peroxisome Proliferator-Activated Receptors in Ovarian Tissue from Naturally Cycling and Pseudopregnant Rats. Biology of Reproduction,2002,66:1531~1539
18 Curry T E Jr, Osteen K G. Cyclic changes in the matrix metalloproteinase system in the ovary and uterus. Biol Reprod.,2001,64:1285~1296
19 Xin X, Yang S, Kowalski J, et al. Peroxisome proliferator-activated receptor y ligand, are potent inhibitors of angiogenesis in vitro and in vivo. J Biol Chem., 1999,274:9116~9121
20 Dreyer C, Krey G, Keller H, et al. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell, 1992,68:879~887
21 Hatae T, Wada M, Yokoyama C, et al. Prostacyclin-dependent apoptosismediated by PPAR delta. J Biol Chem.,2001,276:46260~46267
22 Lim H, Gupta R A, Ma W G, et al. Cyclo-oxygenase-2-derived prostacyclin mediates embryoimplantation in the mouse via PPARdelta. Genes Dev., 1999, 13:1561~1574
23 Narumiya S, Hirata N, Namba T, et al. Structure and function of prostanoid receptors. J Lipid Mediat.,1993,6:155~161
24 Sporn M B, Suh N, Mangelsdorf D J. Prospects for prevention and treatment of cancer with selective PPARgamma modulators(SPARMs).Trends Mol Med.,2001,(7):395~400
25 Song H, Lim H, Das S K, et al. Dysregulation of EGF family of growth factors and COX-2 in the uterus during the preattachment and attachment reactions of the blastocyst with the luminal epithelium correlates with implantation failure in LIF-deficient mice. Mol Endocrinol.,2000,14:1147~1161
26 Gasic S, Bodenburg Y, Nagamani M, et al. Troglitazone inhibits progesteroneproduction in porcine granulosa cells. Endocrinology,1998,139:4962~4966
27 Shi Y, Hon M, Evans RM. The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling. Proc Natl Acad Sci USA,2002,99:2613~2618
28 Lim H, Ma L, Ma WG, Maas RL, Dey SK Hoxa-10 regulates uterine stromal cell responsiveness to progesterone during implantation and decidualization in the mouse. Mol pnrlnrrinnl,1999,l1:1005~1017
29 Krogsdam A M, Nielsen C A, Neve S, et al. Nuclear receptor corepressor-dependent repression of peroxisome proliferator-activated receptor delta-mediated transactivation. Biochem J.,2002,363:157~165
30 Kamijo T, Rajabi M R, Mizunuma H, et al. Biochemical evidence for autocrine/paracrineregulation of apoptosis in cultured uterine epithelia) cells during mouse embryo implantation in vitro. Mol Hum Reprod.,1998, 4:990~998
31 Heinzel T, Lavinsky RM, Mullen TM, et al. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional regression. Nature, 1997,387:43~48
32 Meade E, McIntyre T, Zimmerman G, et al. Peroxisome proliferators enhancecyclooxygenase-2 expression in epithelial cells. J Biol Chem.,1999,274:8328~8334
33 Scherle P A, Ma W, Lim H, et al. Regulation of cyclooxygenase-2 induction in the mouse uterus during decidualization. An event of early pregnancy. J Biol Chem.,2000,275:37086~37092
